68B-29521-01205 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-21
Dose 1 — Pfizer-BioNTech
2021-04-11
Dose 2 — Pfizer-BioNTech
2021-12-10
Dose 3 — Moderna
2021-12-11
Registered in v-safe
2021-12-11
Survey response — days 1–6 daily, dose 3
MedDRA: Unevaluable event — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: resting heart rate of 130bpm

MedDRA releases: 2024-11 · check-in free text available
2021-12-12
Survey response — days 1–6 daily, dose 3
MedDRA: Chest discomfort, Dyspnoea, Heart rate increased, Oedema peripheral — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: high heart rate, swollen left armpit, heavy chest and a hard time taking a deep breath

MedDRA releases: 2024-11 · check-in free text available
2021-12-13
Survey response — days 1–6 daily, dose 3
MedDRA: Blood pressure increased, Heart rate increased, Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, Nausea · Be unable to work or attend school

Free text: Heart is still above normal when testing and worse when standing. Blood pressure still above normal. Injection armpit lymph node still painfully swollen.

MedDRA releases: 2024-11 · check-in free text available
2021-12-16
Survey response — days 1–6 daily, dose 3
MedDRA: Heart rate increased — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: resting heart rate remains high 90-100bpm, and standing or walking makes it go to 115-125bpm

MedDRA releases: 2024-11 · check-in free text available
2021-12-16
Report sent to call center — days 1–6 daily, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-12-17
Survey response — day 7, dose 3
MedDRA: Heart rate increased — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Heart rate remains elevated to 125-130 if doing anything but sitting. Have scheduled follow up with pcp with no improvement

MedDRA releases: 2024-11 · check-in free text available
2021-12-17
Report sent to call center — day 7, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-12-19
Call 1 — Left Voicemail
2021-12-21
Call 1 — Left Voicemail
2022-01-21
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-21	Pfizer-BioNTech	No
2	2021-04-11	Pfizer-BioNTech	No
3	2021-12-10	Moderna	No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-11

Systemic reaction (other): resting heart rate of 130bpm

2021-12-12

Systemic reaction (other): high heart rate, swollen left armpit, heavy chest and a hard time taking a deep breath

2021-12-13

Systemic reaction (other): Heart is still above normal when testing and worse when standing. Blood pressure still above normal. Injection armpit lymph node still painfully swollen.

2021-12-16

Systemic reaction (other): resting heart rate remains high 90-100bpm, and standing or walking makes it go to 115-125bpm

Release 10 — day 7, dose 3

2021-12-17

Systemic reaction (other): Heart rate remains elevated to 125-130 if doing anything but sitting. Have scheduled follow up with pcp with no improvement

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Blood pressure increased	·	·	✓
SRO	Chest discomfort	·	·	✓
SRO	Dyspnoea	·	·	✓
SRO	Heart rate increased	·	·	✓
SRO	Lymph node pain	·	·	✓
SRO	Lymphadenopathy	·	·	✓
SRO	Oedema peripheral	·	·	✓
SRO	Unevaluable event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release